Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Fidia Spa ( (IT:FDA) ) has issued an announcement.
Fidia S.p.A. has reported the conversion of seven bonds from the third tranche of its reserved convertible bond with warrants (POC) by Global Growth Holding Limited at a price of €0.04 per share, resulting in the issuance of 1,750,000 new shares. These shares are immediately admitted to trading, contributing to ongoing capitalization efforts and signaling continued investor engagement in the group’s financial restructuring.
Following this conversion, the POC has been subscribed for a total nominal amount of €750,000, with €660,000 of the related capital increase already executed and nine bonds still subscribed but not yet converted. As a result, Fidia’s share capital rises by €70,000 to €10,507,761.90, and the total number of outstanding shares increases to 39,292,927, moderately diluting existing shareholders while strengthening the company’s equity base.
The most recent analyst rating on (IT:FDA) stock is a Sell with a EUR0.11 price target. To see the full list of analyst forecasts on Fidia Spa stock, see the IT:FDA Stock Forecast page.
More about Fidia Spa
Fidia S.p.A., based in Turin and listed on Euronext Milan, is a global specialist in numerical control technology and integrated high‑performance milling systems. Its products, including numerical controls, high‑speed milling machines and CAM software for complex shapes, serve mainly the automotive mold and aerospace sectors, where it offers end‑to‑end milling process solutions.
Average Trading Volume: 1,135,254
Technical Sentiment Signal: Strong Sell
Current Market Cap: €1.67M
Find detailed analytics on FDA stock on TipRanks’ Stock Analysis page.